CAR T-Cell Therapy for Relapsed/Refractory CLL
2 Visninger
• 07/14/23
0
0
Indlejre
administrator
Abonnenter
The panelists provide insight on the use of chimeric antigen receptor T-cell therapy for chronic lymphocytic leukemia and the TRANSCEND CLL-004 trial of liso-cel (JCAR017) in relapsed/refractory disease.
Vis mere
Facebook kommentarer
SORT BY-
Topkommentarer
-
Seneste kommentarer